File

Sonder Holdings Alert: Class Action Investigation Following Delayed Release of SOND Financial Information, Contact Johnson Fistel, LLP

Retrieved on: 
Monday, March 18, 2024

The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

Key Points: 
  • The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.
  • If you bought securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.
  • Following the delayed filing news, Sonder stock was lower in pre-market trading on March 18, 2024.
  • Individuals with nonpublic information about the Company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Children’s Place, and Ventyx and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, March 16, 2024

On February 9, 2024, before the market opened, The Children’s Place announced its preliminary fourth quarter fiscal year 2023 financial results.

Key Points: 
  • On February 9, 2024, before the market opened, The Children’s Place announced its preliminary fourth quarter fiscal year 2023 financial results.
  • Therein, the Company revealed that it now expected fourth quarter net sales between $454 million and $456 million, falling short of previously issued guidance.
  • In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • As of the time this Complaint was filed, the price of Ventyx common stock continues to trade below the $16.00 per share Offering price, damaging investors.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTYX

Retrieved on: 
Friday, March 15, 2024

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Ventyx is a clinical-stage biopharmaceutical company that develops small-molecule product candidates to address a range of inflammatory diseases.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

The Marquie Group Retires S-1 In Continued Commitment to Shareholders

Retrieved on: 
Thursday, March 14, 2024

ST. PETERSBURG, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- The Marquie Group, Inc. (OTCMKTS: TMGI), a growing force within the health and beauty industry, has announced that as part of its ongoing commitment to its shareholders, management has retired its S-1 registration.

Key Points: 
  • ST. PETERSBURG, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- The Marquie Group, Inc. (OTCMKTS: TMGI), a growing force within the health and beauty industry, has announced that as part of its ongoing commitment to its shareholders, management has retired its S-1 registration.
  • This is another momentous step in addressing the issues that have impacted shareholders and valuation.
  • Additionally, the Company has reiterated its stance that there will be no reverse split, and its authorized shares will be reduced significantly which will be reflected in the upcoming 10-Q filing.
  • Marc Angell, CEO of The Marquie Group , expressed, “To enhance shareholder value and bolster confidence, we are halting the issuance of shares under the S-1 registration effective immediately.

LUNA ALERT: Bragar Eagel & Squire, P.C. is Investigating Luna Innovation, Inc. on Behalf of Luna Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, March 14, 2024

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (“Luna” or the “Company”) (NASDAQ: LUNA) on behalf of Luna stockholders.

Key Points: 
  • NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (“Luna” or the “Company”) (NASDAQ: LUNA) on behalf of Luna stockholders.
  • Our investigation concerns whether Luna has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On March 12, 2024, Luna announced it will delay the release of its fourth quarter and fiscal year 2023 financial results.
  • Following the delayed filing news, Luna stock was 23% lower in pre-market trading on March 13, 2024.

Luna Innovations Alert: Johnson Fistel has Commenced a Class Action Investigation Following Delayed Release of Financial Information

Retrieved on: 
Wednesday, March 13, 2024

If you bought securities and suffered significant losses on your investment, join our investigation now:

Key Points: 
  • If you bought securities and suffered significant losses on your investment, join our investigation now:
    Or for more information, contact Jim Baker at [email protected] or (619) 814-4471.
  • On March 12, 2024, Luna announced it will delay the release of its fourth quarter and fiscal year 2023 financial results.
  • Following the delayed filing news, Luna stock was 23% lower in pre-market trading on March 13, 2024.
  • Individuals with nonpublic information about the Company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Children’s Place, and Ventyx and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, March 12, 2024

On February 9, 2024, before the market opened, The Children’s Place announced its preliminary fourth quarter fiscal year 2023 financial results.

Key Points: 
  • On February 9, 2024, before the market opened, The Children’s Place announced its preliminary fourth quarter fiscal year 2023 financial results.
  • Therein, the Company revealed that it now expected fourth quarter net sales between $454 million and $456 million, falling short of previously issued guidance.
  • In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • As of the time this Complaint was filed, the price of Ventyx common stock continues to trade below the $16.00 per share Offering price, damaging investors.

VIA optronics AG Announces Change in Management Board

Retrieved on: 
Thursday, April 4, 2024

VIA optronics AG (NYSE: VIAO) (“VIA” or the “Company”), a leading supplier of interactive display systems and solutions, today announced that Dr. Markus Peters has resigned from his role as Chief Financial Officer (“CFO”) and as a member of VIA's Management Board, effective March 31, 2024.

Key Points: 
  • VIA optronics AG (NYSE: VIAO) (“VIA” or the “Company”), a leading supplier of interactive display systems and solutions, today announced that Dr. Markus Peters has resigned from his role as Chief Financial Officer (“CFO”) and as a member of VIA's Management Board, effective March 31, 2024.
  • Chairman of the Supervisory Board Dr. Heiko Frank commented, “On behalf of the Supervisory Board, I would like to thank Dr. Peters for taking on the role of CFO and Member of the Management Board during a challenging period for the Company.
  • He has been a valued member of our management team, and we wish him the best in his next endeavors.”
    Dr. Peters said, “I would like to thank the Supervisory Board and the whole VIA team for their support, trust and engagement.
  • Mr. Wagner is managing the completion and filing of the Company’s financial statements.

Allstate to discuss first quarter 2024 earnings with investors

Retrieved on: 
Wednesday, April 3, 2024

The Allstate Corporation (NYSE: ALL) will host a conference call and webcast at 9 a.m. Eastern on Thursday, May 2, 2024, to discuss first quarter 2024 earnings.

Key Points: 
  • The Allstate Corporation (NYSE: ALL) will host a conference call and webcast at 9 a.m. Eastern on Thursday, May 2, 2024, to discuss first quarter 2024 earnings.
  • To view Allstate’s quarterly results after their filing, including the earnings release and investor supplement, visit the SEC website at www.sec.gov .
  • Visit www.allstateinvestors.com for the following:
    Review the Form 8-K, including the earnings release and investor supplement, after filing.
  • Stay up to date about financial information, like material announcements about The Allstate Corporation, which is routinely posted.

Check to Power Wave’s Expanded Payroll Offering

Retrieved on: 
Wednesday, April 3, 2024

Over 300,000 small businesses that use Wave will soon have access to best-in-class full-service payroll functionality across all 50 U.S. states.

Key Points: 
  • Over 300,000 small businesses that use Wave will soon have access to best-in-class full-service payroll functionality across all 50 U.S. states.
  • Instead of needing the necessary payroll funds in advance, small business owners simply need to have funds available the day of payroll processing.
  • Human-powered customer service: Wave customers will have access to a range of resources to assist with payroll questions, including support from payroll experts.
  • We’re excited to see Check’s embedded payroll help solidify Wave’s position as a leading one-stop-shop for small business management needs.”